Literature DB >> 11835433

Epidemiology of primary blepharospasm.

Giovanni Defazio1, Paolo Livrea.   

Abstract

We review epidemiological data on primary blepharospasm (BSP). There is a large variation in the stated prevalence of BSP, with crude estimates ranging from 16 to 133 per million in different studies. A large proportion of this variability may be the result of differences in physician education on BSP. Age and female gender may increase the risk of developing BSP. The few case-control studies focusing on adult dystonias including BSP showed an increased risk in association with family history of dystonia and/or postural tremor, prior head and face trauma, and prior eye disease (e.g., blepharitis and keratoconjunctivitis), and a decreased risk associated with cigarette smoking. No association was found with age-related medical conditions such as hypertension and diabetes, family history of parkinsonism, and a history of anxiety or depression. Broocks et al. [Am J Psychiatry, 1998;155:555-557] found a significantly higher frequency of obsessive-compulsive symptoms in BSP than hemifacial spasm despite the clinical similarity. Among putative risk factors for BSP, age at onset, female gender, and prior head or face trauma may affect spread of dystonia to adjacent body regions. While limited, the body of epidemiological data support the idea that environmental and familial, possibly genetic, factors may both be important in the etiology of BSP. Copyright 2001 Movement Disorder Society.

Entities:  

Mesh:

Year:  2002        PMID: 11835433     DOI: 10.1002/mds.1275

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  13 in total

1.  Clinical features of patients with blepharospasm: a report of 240 patients.

Authors:  E L Peckham; G Lopez; E A Shamim; S Pirio Richardson; S Sanku; R Malkani; M Stacy; P Mahant; A Crawley; A Singleton; M Hallett
Journal:  Eur J Neurol       Date:  2011-03       Impact factor: 6.089

Review 2.  Meige syndrome: what's in a name?

Authors:  Mark S LeDoux
Journal:  Parkinsonism Relat Disord       Date:  2009-05-19       Impact factor: 4.891

Review 3.  Botulinum toxin in the management of blepharospasm: current evidence and recent developments.

Authors:  Amy Hellman; Diego Torres-Russotto
Journal:  Ther Adv Neurol Disord       Date:  2015-03       Impact factor: 6.570

4.  Head trauma in primary cranial dystonias: a multicentre case-control study.

Authors:  Davide Martino; Giovanni Defazio; Giovanni Abbruzzese; Paolo Girlanda; Michele Tinazzi; Giovanni Fabbrini; Maria Stella Aniello; Laura Avanzino; Carlo Colosimo; Giovanni Majorana; Giuseppe Majorana; Carlo Trompetto; Alfredo Berardelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-10-20       Impact factor: 10.154

5.  Long-term treatment of blepharospasm with botulinum toxin A: a service-based study over a 16-year follow-up in southern China.

Authors:  Xiao-Bo Fang; Meng-Shu Xie; Zu-Biao Song; Zhi-Gang Zhong; Ying Wang; Zi-Lin Ou; Chao Dang; Ling Li; Wei-Xi Zhang
Journal:  Neurol Sci       Date:  2019-11-19       Impact factor: 3.307

Review 6.  Primary blepharospasm: diagnosis and management.

Authors:  Giovanni Defazio; Paolo Livrea
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Surgical approach to limiting skin contracture following protractor myectomy for essential blepharospasm.

Authors:  Jeremy Clark; John Randolph; Jason A Sokol; Nicholas A Moore; Hui Bae H Lee; William R Nunery
Journal:  Digit J Ophthalmol       Date:  2017-11-05

Review 8.  Obsessive-compulsive disorder and its related disorders: a reappraisal of obsessive-compulsive spectrum concepts.

Authors:  Dennis L Murphy; Kiara R Timpano; Michael G Wheaton; Benjamin D Greenberg; Euripedes C Miguel
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

9.  Comparable Botulinum Toxin Outcomes between Primary and Secondary Blepharospasm: A Retrospective Analysis.

Authors:  Daniel Martinez-Ramirez; Juan C Giugni; Erin Hastings; Aparna Wagle Shukla; Irene A Malaty; Michael S Okun; Ramon L Rodriguez
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2014-12-15

Review 10.  Eyelid Dysfunction in Neurodegenerative, Neurogenetic, and Neurometabolic Disease.

Authors:  Ali G Hamedani; Daniel R Gold
Journal:  Front Neurol       Date:  2017-07-18       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.